Markets:

Overview

News

Currencies

International

Treasuries

Arrowhead Pharmaceuticals, Inc. - Common Stock (NQ:ARWR)

63.59 -0.27 (-0.42%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Arrowhead Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Mid-Day Market Update: Dow Surges Over 100 Points; Arrowhead Pharmaceuticals Shares Plummet ↗

July 02, 2021

Midway through trading Friday, the Dow traded up 0.33% to 34,747.45 while the NASDAQ rose 0.50% to 14,594.85. The S&P also rose, gaining 0.47% to 4,340.12. The U.S. has the...

Via Benzinga

Topics Stocks

Here's Why Arrowhead Pharmaceuticals Stock Is Getting Hammered Today ↗

July 02, 2021

A paused clinical trial with an important asset wasn't what investors wanted to hear today.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 02, 2021

Gainers Alector (NASDAQ:ALEC) stock moved upwards by 39.93% to $31.36 during Friday's pre-market session. The market value of their outstanding shares is at $2.5...

Via Benzinga

Arrowhead Stock Drops After RNAi Therapeutic Shows Lung Inflammation In Animal Models ↗

July 02, 2021

Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) has voluntarily paused the AROENaC1001 Phase 1/2 study evaluating ARO-ENaC for cystic fibrosis. ARO-ENaC is the...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗

June 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

Horizon Acquires Rights to Arrowhead's RNAi-Based Gout Treatment Candidate ↗

June 21, 2021

Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) and Horizon Therapeutics plc (NASDAQ: HZNP) have entered into a global collaboration and license agreement ...

Via Benzinga

The Week In Charts - Why You Can't Trade, Or Maybe You Can? ↗

June 18, 2021

In this video, I look at the reasons for why you may or may not be able to trade. I also continue my discussion on finding

Via Talk Markets

Biotech Movers During ASCO Week ↗

June 12, 2021

The biotech sector performed well in a good ASCO week. And many biotech stocks were movers this week as a bullish sentiment took hold sparked by the Biogen Aduhelm approval.

Via Talk Markets

Vertex Pharma Stumbles In Rare-Disease Effort, Buoying Rival Arrowhead Pharma ↗

June 10, 2021

Vertex Pharmaceuticals scrapped development of a rare-disease treatment Thursday that appeared unlikely to benefit patients, and VRTX stock plunged.

Via Investor's Business Daily

Arrowhead Receives $10M Option Exercise Fee From Janssen ↗

May 18, 2021

Janssen Pharmaceuticals Inc, part of Johnson & Johnson (NYSE: JNJ), has delivered written notice of its intent to exercise its option right for ARO-JNJ1....

Via Benzinga

Arrowhead Pharmaceuticals, Inc (ARWR) Q2 2021 Earnings Call Transcript ↗

May 05, 2021

ARWR earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Arrowhead's ARO-AAT Treatment Associated With Improved Fibrosis In Patients With Alpha-1 Liver Disease ↗

April 28, 2021

Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) has announced positive interim 48-week liver biopsy results from the Phase 2 AROAAT2002 study ...

Via Benzinga

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Arrowhead Pharmaceuticals, Inc. - Common Stock (NQ:ARWR)

Headline News about Arrowhead Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today